LYNN NGUYEN: Open Payments
NPI 1346746856 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,303 in 267 payments from 24 companies in 2025. Trend: 2023 $3,977 · 2024 $3,747 · 2025 $5,303
Food & beverage: $4,856Consulting: $250Education: $197
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 49 | $963 |
| ABBVIE INC. | 19 | $602 |
| Janssen Biotech, Inc. | 15 | $481 |
| PFIZER INC. | 19 | $337 |
| Medimetriks Pharmaceuticals, Inc. | 5 | $328 |
| MAYNE PHARMA COMMERCIAL LLC | 44 | $325 |
| GENZYME CORPORATION | 17 | $303 |
| LEO Pharma Inc. | 10 | $294 |
| Regeneron Healthcare Solutions, Inc. | 10 | $225 |
| Arcutis Biotherapeutics, Inc. | 21 | $208 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, RINVOQ, CIBINQO, Neo-Synalar, SKYRIZI, Zoryve.
Industry payments across TX — which companies pay providers there.
